Extractions: Choose here! lambda FITC / CD19 PE kappa FITC / CD19 PE anti-human C5b-9 (aE11) CD3 (UCHT-1) CD3 (CRIS-7) CD4 (EDU-2) CD5 (CRIS-1) CD8 (UCHT-4) CD8 (5C2-2H2) IgM clone CD15 (BRA-4F1) CD16+CD56 PE CD16 (MEM-154) CD20 (CAT 13.6E12) CD56 (MEM-188) anti-IgM (IIE2) anti-kappa (A8B5) anti-lambda (4C2) CD3 FITC / CD16+CD56 PE CD3 FITC / CD19 PE CD3 FITC / CD8 PE CD4 FITC / CD8 PE CD45 FITC / CD14 PE CD5 FITC / CD19 PE HLA DQ (FN81) HLA DR (EDU-1) pan HLA Class II (HKB1) human IgE (HE1) Isotype control IgG1 (1B9) Isotype control IgG2a (BH1) Isotype control IgG2a (5A7)
Lymphoma -- ECureMe.com UPDATED SARS INFORMATION,Check health symptoms, make a self diagnosis, ask adoctor or veterinarian online, view an encyclopedia of diseases treatments, http://www.ecureme.com/emyhealth/data/Lymphoma.asp
Extractions: DisplayAd("468","60"); eCureMe Life : Your Healthy Living. Click Here! Welcome, eCureMe.com Select a Health Topic ADD/ADHD Allergy Alternative Medicine Arthritis Asthma Beyond Dieting Body Aches and Pains Breast Cancer Cancer Awareness Cardio Health Children's Health Colon Cancer Contraception COPD/Emphysema Dental Health Diabetes Elder Care Emergency Room Epilepsy Erectile Dysfunction Eye Care Fertility Fitness Gastrointestinal Health Glands and Hormones Gynecologic Health Hair Loss Headache Healthcare Today Healthy Aging HIV and AIDS Infectious Diseases Kidney Health Leukemia Liver Health Lung Cancer Lymphoma Multiple Sclerosis Men's Health Mental Health Nutrition Osteoporosis Parkinson's Disease Sexual Health Skin Health Sleep Disorders Special Events Stroke Surgeries and Procedures Teen Health Thyroid Health Urologic Health Vascular Disease Women's Health Workplace Health September 9, 2005 eCureMe Life Medical Supplies Calorie Count Physician Search ... Hospital Directory
Childhood Non-Hodgkin's Lymphoma Childhood nonHodgkin s lymphoma is a disease in which cancer ChildhoodNon-Hodgkin s lymphoma (UK) a factsheet produced by the United Kingdom http://www.cancerindex.org/ccw/guide2q.htm
Extractions: Childhood Non-Hodgkin's Lymphoma Menu Cancer-Types NHL The lymphatic system helps the body fight infection. There are two main types of cancer associated with the lymphatic system: Hodgkin's Disease and Non-Hodgkin's Lymphoma (NHL). Both are rare in children aged under 3, and are more common in older children and adults. More boys than girls have childhood Hodgkin's disease.Childhood non-Hodgkin's lymphoma is a disease in which cancer (malignant) cells are found in the lymphatic system. See also General / Adult Lymphoma Resources in InterNet Resources for Cancer) Parent's information for Childhood Non-Hodgkin's Lymphoma (CancerNet) Information about the disease, staging, and treatment overviews. It is reviewed each month by a panel of medical experts. Childhood Lymphomas (Health Canada) in the booklet "This Battle Which I Must Fight" Childhood Lymphomas (CancerNews on the Net) an article by Faith H. Kung, M.D Childhood NHL (Lymphoma Information Network) The pages include information about childhood Hodgkin's, diagnosis, treatment, and a kid's page. The site is produced by a lymphoma survivor. Childhood Non-Hodgkin's Lymphoma (UK) a factsheet produced by the United Kingdom Children's Cancer Study Group and CancerBacup linked to the UKCCSG booklet "A Parent's Guide to Children's Cancers".
Children's Leukemia Foundation Of Michigan Statewide organization which provides information, financial assistance, and emotional support to families of adults and children affected by leukemia, lymphoma, and other related blood disorders. http://www.leukemiamichigan.org/
Cancer Care : Lymphoma Get detailed information on lymphoma from the American Cancer Society. CancerNet NCI The lymphoma Research Foundation of America, Inc. is a national, http://www.cancercare.org/InternetLinks/InternetLinks.cfm?ID=3639&c=123
Extractions: The Trust was formed in Marc's memory for the sole purpose of raising funds to finance research into new and hopefully more successful treatment for Hodgkins Disease and Non Hodgkins Lymphoma and to produce a vaccine against re-occurrence of the disease after treatment. This research is being carried out at The Royal Free Hospital, Hampstead NW London, where Marc was treated throughout his illness. The Trust received charitable status in April 1995. The Marc Fisher Trust NEEDS YOUR SUPPORT HELP US TURN RESEARCH INTO REALITY PLEASE MAKE YOUR DONATION NOW Click Donate Thank you for your support This will help to Save young lives MARC FISHER TRUST
Lymphoma Treatment for nonHodgkin s lymphoma depends on stage of the disease and may include Non-Hodgkin s lymphoma is more common in men than in women. http://www.fhcrc.org/research/diseases/lymphoma/
Extractions: Delivering targeted, less toxic treatment to lymphoma's most vulnerable victims Harnessing the immune system to prevent relapse after transplantation Using the immune system to improve stem cell transplant outcomes High-dose chemotherapy regimens ... Mini-transplants offer new hope to patients Relevant Articles Hutchinson Center Publications Description of the Disease Lymphomas are cancers affecting the lymphatic system, the network of vessels and nodes that carry infection-fighting white cells, called lymphocytes, throughout the body. Lymphomas are generally classified as Hodgkin's disease and non-Hodgkin's lymphoma. In both types of cancer, the lymphatic cells begin to grow abnormally. Hodgkin's disease follows a more predictable pattern, and tends to have a more limited spread. It is typically treated with radiation or chemotherapy. Non-Hodgkin's lymphomas, on the other hand, may begin in a variety of places in the body, since lymphatic tissue is present in many different organs. Treatment for non-Hodgkin's lymphoma depends on stage of the disease and may include radiation, chemotherapy or a bone-marrow transplant. Back to Top Who is at Risk?
Extractions: var externalLinkWarning = "The link you have selected will take you to a site outside Merck and The Merck Manuals.*n*nThe Merck Manuals do not review or control the content of any non-Merck site. The Merck Manuals do not endorse and are not responsible for the accuracy, content, practices, or standards of any non-Merck sources."; Search The Second Home Edition , Online Version Search Index A B C D ... Z Sections Accidents and Injuries Blood Disorders Bone, Joint, and Muscle Disorders Brain, Spinal Cord, and Nerve Disorders ... Women's Health Issues Resources Anatomical Drawings Multimedia Pronunciations Weights and Measures ... , Online Version Section Blood Disorders Chapter Lymphomas Topics Introduction Hodgkin's Disease Non-Hodgkin's Lymphomas Non-Hodgkin's Lymphomas Buy The Book Print This Topic Email This Topic Pronunciations autologous B lymphocytes Burkitt's lymphoma corticosteroid ... prednisone Non-Hodgkin's lymphomas are a diverse group of cancers that develop in B or T lymphocytes. This group of cancers is actually more than 20 different diseases, which have distinct appearances under the microscope, different cell patterns, and different clinical courses. Most non-Hodgkin's lymphomas (85%) are from B cells; less than 15% develop from T cells. Non-Hodgkin's lymphoma is more common than Hodgkin's disease. In the United States, about 65,000 new cases are diagnosed every year, and the number of new cases is increasing, especially among older people and people whose immune system is not functioning normally. Those at risk include people who have had organ transplants and some people who have been infected with the human immunodeficiency virus (HIV).
Lymphoma Inside The Eye And Central Nervous System What is common to most of these reports is that, when the lymphoma is found inthe brain, Primary intraocular lymphoma diagnosis and management. http://www.eyecancer.com/conditions/Infiltrative Tumors/lymphoma.html
LYMPHOMA lymphoma Received a call todayfrom an oncologist who evaluated a 40 yr old male who had a localized 1 cm http://dermatology.cdlib.org/rxderm-archives/lymphoma
Extractions: LYMPHOMA - Received a call today from an oncologist who evaluated a 40 yr old male who had a localized 1 cm area of induration of scalp excised by his GP (good grief). They could find no evidence of systemic involvement. The oncologist (not able to get authorization yet from the patient's HMO GP) called and asked me what to do. Local radiation tx? Nitrogen mustard? PUVA? No treatment until new lesion? It is not a T cell lesion which was confirmed by appropriate immunotyping etc. Robert M. Peppercorn, M.D. x-ray therapy would seem to be the leading candidate for localized B-cell lymphoma on the skin. I dare say you''ll havle difficulty finding anything in print describing success rates with any other modality. Mark Valentine Having the experience of seeing two cases of b-cell lymphoma presenting in the skin I would offer the following observations. If the lesion is truly isolated and there can be no nodal involvement demonstrated I have one patient, a local internist by the way, who had the area irradiated. Her workup and radiation was done at the NIH. She is at least 15 years post at this point and disease free as far as I know. My second patient presented when she as about 70 with diffuse nodular involvement of the skin. Her nodules did not respond well to electron beam because of their depth and she did not have demonstrable internal involvement for 10 or more years. When she did get internal involvement it did not seem to slow her down and she died with heart problems at 85 years of age. She also had a few attempts at systemic chemo with very little effect on her disease. Some of her lesions were intensely pruritic and this was resolved by my local injections of triamcinolone 2.5 mg/cc. The nodules also went away after injection so when she was getting them on her face she ask me to inject those because of their rather unsightly appearance. I hope these anecdotes may be of some help. L.J. Gregg,MD
Extractions: Welcome to Herbs for Cancer . We are dedicated in helping those that are faced with cancer. This is a challenging time. Cancer is a process that takes years to develop, this happens when the body becomes weak and no longer can fight the cancer. Chinese Herbs have been used for over 5000 years. Herbs have been used to strengthen the body and bring it back to a balanced state. When the body is strong, it can fight and destroy cancer. Let me tell you Herbs work! They are more effective if taken in their natural state, that is raw herbs made into a tea. That is what Herbs for Cancer does here. We provide you herbs in the raw form in a pure cotton bag that you boil to make tea the same way it has been done for thousands of years. I have spent over 10 years researching which herbs are best for which type of cancer, there are hundreds of documentations for these herbs. If you want to fight cancer and win you have to get healthy and help your body fight. You cannot treat every cancer the same, that is why each formula is different for each type of cancer. Please look at the link for the type of cancer that you need to treat and start today, don't let your body become weaker, begin to fight now. If you don't see a link for the cancer you have please contact us and we will make a formula for the cancer you need treated.
Extractions: CASE The patient is a 44 year old man who first noted decreased vision in the left eye in October 93, then in the right eye in January 94. He was examined by his ophthalmologist, who told him that he had "retinal inflammation and swelling." He was treated with prednisone 60 mg a day, and prednisolone acetate 1% every hour in both eyes. His vision improved minimally with the treatment. He also had numerous blood tests and a chest X-ray, which reportedly were all within normal limits. He was examined by a neuro-ophthalmologist, and had an MRI of the brain, which was also normal. Figure 1 These lesions were also found scattered nasally and inferiorly to the optic disc. (Fig. 2) Figure 2 Figure 3 Figure 4 Fluorescein angiogram of the right fundus showed areas of hyperfluorescence in the central macula and superior to the disc, which corresponded to some of the lesions noted on exam. (Fig. 5) Figure 5 Late frames of the angiogram showed persistence of the hyperfluorescence.
The Cancer Infomation Network NonHodgkin s lymphoma is a group of malignant diseases develops from the lymphatic Eating Lots of Vegetables May Help Prevent Non-Hodgkin s lymphoma http://www.cancerlinksusa.com/lymphoma/
Extractions: First Steps After Diagnosis of Cancer Top 10 Cancer Sites, Treatment Centers, and Cancer Books for Newly Diagnosed Patients. Cancer Patients: Known Your Rights. Understanding Prognosis and Cancer Statistics - answers the most important question, "What is my prognosis?" Support Groups for Cancer Patients ... Pediatric Cancers Welcome to The Cancer Information Network Redirecting to new URL The Cancer Information Network is a physician guided website for cancer patients and their caregivers. Page is loading, please wait If you aren't automatically transferred within 2 seconds, please click here: http://www.thecancer.info/lymphoma/index.asp Also Recommends Subscribe the monthly newsletter of The Cancer Informa-
Extractions: Site Navigation Non-Hodgkin's lymphoma is a malignant (cancerous) growth of B or T white blood cells (lymphocytes) in the lymph system . The Non-Hodgkin's lymphomas encompass over 29 types of lymphoma, each a bit different. Cases of the Non-Hodgkin's lymphoma far outweigh cases of Hodgkin's Lymphoma (Disease) - a separate category of lymphatic cancers. A medical diagnosis or symptoms of Non-Hodgkin's Lymphoma can be scary - it need not be. There are some very effective treatments available, many new in the last 5 to 10 years. While a cancer diagnosis is never a good thing, there is true hope that the cancer can be eradicated. To help you please follow through pages on lymphoma below: Information on Adult Non-Hodgkin's lymphoma For information on Childhood Lymphomas: Other Non-Hodgkin's Pages The Main Page - your guide to support and more: Site Map Search this Site This page is a work in progress. The author is not in the medical field and does not warrant the correctness of the material on this page or the sites linked - please take online information and consult with your own medical team to make informed decisions.
Extractions: This radiograph represents the pretreatment image of a patient with lymphoma manifest as a huge anterior mediastinal mass. The lung fields otherwise are generally clear. The post-treatment x-ray shows calcified lymph nodes in the right hilum with reduction in the anterior mediastinal mass. The cell-type was Hodgkin's. CT scan better defines the relationship of the mediastinal mass with the cardiac silhouette and great vessels. Anatomy Thoracic landmarks Lateral landmarks Heart radiographs Thoracic anatomy Cardiac anatomy Cardiac valves ANT view LAO view LAT view SA view Cross-sectional views Blood supply ANT coronaries LAO coronaries LAT coronaries RAO coronaries Bronchioles Breast anatomy Techniques Ionizing vs nonionizing Tomography vs projection Ionizing radiation Electromag. spectrum Tomography Radiography Radiographic density Rad. gray scales CT imaging Planar imaging Planar anatomy SPECT imaging SPECT anatomy ERNA Echocardiography Transesophageal Magnetic resonance Cases Aortic aneurysm Aortic regurgitation Atelectasis Carcinoma Carcinoma, ductal
Extractions: Scientists at Bath Cancer Research undertake ex vivo drug sensitivity studies using the TRAC assay (Tumour Response to Anti-neoplastic Compounds, a development of the DiSC assay [Ref 10 of Selected Publications ]). With this we assess the cytotoxic drug sensitivity of fresh human cells from patients with leukaemia and lymphoma. Our greatest expertise is with chronic lymphocytic leukaemia (CLL), acute myeloid leukaemia (AML or ANLL), non-Hodgkin's lymphoma (NHL) and similar diseases. Service Bath Cancer Research provides consultant haematologists/ oncologists an international service for the diseases above. Cells from their patients are tested for ex vivo drug response to a panel of cytotoxic drugs (up to 25 drugs). A report is sent to the physician to aid choice of optimum therapy. This information helps maximise the likelihood of response (and therefore survival) and reduces the risk of causing patient toxicity with no clinical benefit. Some assays are chargeable. For those interested in assays for solid tumours or tests in the USA, please see links at the bottom of this page.